Voices of Alzheimer’s in the News
-
I took the now-defunct Alzheimer's medication for seven years and it 'paused' my disease - without it there's no hope
Geri Taylor benefitted from now-discontinued Alzheimer's drug for seven years
-
Opinion: Don't restrict Alzheimer's treatments for patients like me
VoA Champion Dan Jaworski expresses his concerns over the lack of treatment options available for individuals living with the disease
-
Medicare is stealing time from Alzheimer's patients
VoA Champion Mike Zuendel addresses frustration with CMS in light of newly approved Alzheimer’s treatments
-
For Alzheimer’s patients, a new era of treatment brings hope and risk
VoA Board Member Jay Reinstein was interviewed by the Washington Post about accessing Leqembi, a new drug that slows Alzheimer’s disease.
-
Opinion: The Four Corners is unlikely to benefit from a promising Alzheimer’s treatment
VoA Champion, Dr. Alan Schooley
-
Opinion: Medicare’s Alzheimer’s drug plan won’t help patients like me
VoA Champion Michele Hall
-
VOICES: Advocate for Medicare coverage of new Alzheimer’s treatments
VoA Member Bob Toia
-
An Alzheimer's drug shows promise; Fayetteville protesters want Medicare to cover it
VoA Board Member Jay Reinstein protests for Medicare coverage of Alzheimer’s drugs
-
Pricey Alzheimer’s Drug Coverage Hinges on FDA Decision
VoA Board Members Sue Peschin and Jay Reinstein were interviewed by Bloomberg, weighing in on the Medicare coverage of Leqembi
-
Philip Gutis: When the Government Doomed Alzheimer's Patients
VoA Board Member Philip Gutis wrote an op-ed for the Post-Gazette about recent breakthroughs in Alzheimer’s